June 20, 2025 C-Path Launches Global Collaborative to Advance Drug Development for Neonatal Brain Injury TUCSON, Ariz., June 20, 2025 — The Critical Path Institute® (C-Path), through its International Neonatal Consortium (INC), is p
June 20, 2025 C-Path’s T1D Consortium to Release a Clinical Trial Simulation Tool for New-Onset Trial Design The tool will help researchers design more efficient, effective clinical trials in new-onset type 1 diabetes. TUCSON, Ariz., June
June 18, 2025 C-Path’s Translational Therapeutics Accelerator Announces New Grant Award for Drug Development Project in Type 1 Diabetes TUCSON, Ariz., June 18, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) proudly anno
June 16, 2025 New Paper in Nature Reviews Drug Discovery Highlights How to Maximize the Regulatory Impact of Consortium-Based Projects The paper, by authors from IHI and the Critical Path Institute, highlights the importance of a structured, strategic approach to r
June 4, 2025 C-Path’s Translational Therapeutics Accelerator, Sontag Foundation Award Grant for Drug Development Project Targeting Pediatric Brain Tumors C-Path today announced that its Translational Therapeutics Accelerator (TRxA) program...
May 29, 2025 Critical Path Institute and Citizen Health Partner to Accelerate Drug Development for Neuromuscular Disorders SAN FRANCISCO and TUCSON, Ariz., May 29, 2025 — Critical Path Institute® (C-Path), a global nonprofit accelerating drug develop
May 12, 2025 C-Path’s Translational Therapeutics Accelerator Awards $815,000 Grant for Drug Development Project in Advanced Prostate Cancer Brisbane-based Queensland Emory Drug Discovery Initiative team awarded funding to advance novel therapy for treatment-resistant pr
May 8, 2025 Critical Path Institute Celebrates 20 Years of Advancing Drug Development through Innovation and Collaboration The year 2025 marks a historic milestone for C-Path as the organization celebrates...
May 6, 2025 C-Path Announces First Data Transfer from Takeda to Accelerate Alpha-1 Innovation TUCSON, Ariz., May 6, 2025 — Critical Path Institute’s® (C-Path) Critical Path for Alpha-1 (CPA-1) consortium is proud to ann
April 23, 2025 C-Path Recognizes HIE Awareness Month, Calls for Global Collaboration to Accelerate Neonatal Drug Development TUCSON, Ariz., April 22, 2025 — Critical Path Institute® (C-Path), through its International Neonatal Consortium (INC), jo